Basilea Pharmaceutica
Switzerland - AllschwilBiotechnology
Focus: Basilea Pharmaceutica is a Swiss-based public biotechnology company focused on topical and systemic therapeutics across oncology, infectious diseases, immunology, metabolic diseases, and gastroenterology. The company maintains a diversified pipeline spanning early-stage discovery through late-stage development.
Profile data last refreshed 3h ago · AI intelligence enriched 4d ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at Basilea Pharmaceutica?
AI assessmentBasilea offers meaningful science in niche therapeutic areas but limited hiring visibility and potential revenue constraints may restrict career growth and stability.
Why Work Here
- Access to a diverse pipeline with 18 active programs spanning multiple therapeutic areas, including Phase 3 assets in infectious diseases (ceftobiprole, fosmanogepix) and dermatology (alitretinoin) with near-term catalysts.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Help build intelligence for Basilea Pharmaceutica
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.